Showing 1 posts of 1 posts found.


First patient dosed in AdvanCell’s phase 1/2 trial for prostate cancer treatment

November 9, 2023
Research and Development AdvanCell, Cancer, Oncology, clinical trial, prostate cancer

AdvanCell has announced that the first patient has been dosed with 212Pb-ADVC001 in its phase 1/2 trial for the PSMA-positive …

Latest content